Cargando…
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress
Gastroesophageal adenocarcinoma (GEA) represents a heterogeneous disease and, when diagnosed as locally advanced or metastatic, it is characterized by poor prognosis. During the last few years, several molecular classifications have been proposed to try to personalize treatment for those patients di...
Autores principales: | Gambardella, Valentina, Fleitas, Tania, Tarazona, Noelia, Papaccio, Federica, Huerta, Marisol, Roselló, Susana, Gimeno-Valiente, Francisco, Roda, Desamparados, Cervantes, Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564841/ https://www.ncbi.nlm.nih.gov/pubmed/32971757 http://dx.doi.org/10.3390/jcm9093049 |
Ejemplares similares
-
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020) -
Personalized Medicine: Recent Progress in Cancer Therapy
por: Gambardella, Valentina, et al.
Publicado: (2020) -
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
por: Cabeza-Segura, Manuel, et al.
Publicado: (2022) -
Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Huerta, Marisol, et al.
Publicado: (2021) -
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer
por: Tarazona, Noelia, et al.
Publicado: (2020)